Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Nascobal to be commercialized outside U.S. for vitamin B12 deficiency

Oct. 28, 2010

MacroGenics and Pfizer enter into DART collaboration and license agreement

Oct. 28, 2010

Evotec and Apeiron Biologics collaborate on DREAM modulators for pain

Oct. 28, 2010

Celtic Therapeutics and Resolvyx Pharma form ophthalmology alliance

Oct. 27, 2010

Boehringer Ingelheim and MacroGenics to codevelop antibody-based therapeutics

Oct. 27, 2010

Pfizer gains exclusive global rights to commercialize several of Biocon's insulin products

Oct. 27, 2010

Cellectis and Kyoto University join forces for stem cell research

Oct. 26, 2010

NeuroVive and to-BBB to codevelop therapies for stroke and other CNS disorders

Oct. 26, 2010

Biogen Idec and Genentech amend collaboration agreement on CD20-targeting antibodies

Oct. 25, 2010

Depomed delivers prototype formulation of fixed-dose metformin/canagliflozin

Oct. 25, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...